Christopher Hurt is an Infectious Disease physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Manning Drive Cb#7030
Chapel Hill, NC 275997030
Telephone
984-974-7198Provider last certified this registry record 22 Jun 2020.
Clinical trials
- Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Multimodal Exercise Training Poststroke
Sponsor: University of Alabama at Birmingham
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
93.1%Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor25%Pifeltro43%Efavirenz-Emtric-Tenofov Disop38%Etravirine19%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor14.7%Isentress53%Tivicay47%Part D<11 patients+ 8 more classes in this area
Cardiovascular
6.9%Statin6.9%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2013–2025 per NIH RePORTER. The latest:
- Carolinas United to End HIV Scientific Working Group
Univ of North Carolina Chapel Hill
FY2025$48,056P30AI050410 - NC Collaborative HIV Epidemiology and Prevention (NC-CHEP) SWG
Univ of North Carolina Chapel Hill
FY2024$47,533P30AI050410 - NC Collaborative HIV Epidemiology and Prevention (NC-CHEP) SWG
Univ of North Carolina Chapel Hill
FY2023$62,547P30AI050410
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”